Main > ONCOLOGY (**) > Lung>NSCLC>MET>or RECURRENT > TREAT.: > USA. B. PD-1 MAb+CTLA-4 MAb+Pt CT

---

USA. B. PD-1 MAb+CTLA-4 MAb+Pt CT's subsections
(*) CA Approval Date: 2020. 08.11.
(*) EU Approval Date: 2020. 11.06.
(*) USA Approval Date: 2020. 05.26.
Company
CTLA: Cytotoxic T Lymphocyte>
Generic Names>
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2020. 09.15.
RTM

USA. B. PD-1 MAb+CTLA-4 MAb+Pt CT's products
This section has no products